Skip to main content
Fig. 5 | Journal for ImmunoTherapy of Cancer

Fig. 5

From: Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies

Fig. 5

Sequential treatment with Lm-ANXA2 and anti-PD-1 blockade antibody in genetically engineered KPC mice with spontaneous PDAC tumors resulted in prolonged survival. a Schema of treatment of genetically engineered KPC mice. b Representative ultrasound images of tumors before and after responding to the treatment with Lm-ANXA2/anti-PD-1 antibody. c Kaplan Meier survival curves of KPC mice treated with Lm-ANXA2 followed by anti-PD-1 antibody (n = 12) and control KPC mice (n = 8)

Back to article page